Geriatrics
News, opinions and meeting coverage in primary care.
<ѻý>Droxidopa for OH Slammed by FDA Reviewersѻý>
SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.
Jan 13, 2014